Broeker, A.
Wicha, S. G.
Dorn, C.
Kratzer, A.
Schleibinger, M.
Kees, F.
Heininger, A.
Kees, M. G.
Häberle, H.
Funding for this research was provided by:
Pfizer (WS2030571)
Article History
Received: 20 August 2018
Accepted: 26 November 2018
First Online: 17 December 2018
Ethics approval and consent to participate
: The study protocol was approved by the ethics committee at the medical faculty of the University of Tübingen (no. 057/2013AMG1) and the German Federal Institute for Drugs and Medical Devices (Eudra-CT number 2012–005617-39).
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.